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Effects of histamine and its receptor antagonists on peritoneal perme-
ability. Peritoneal fluid and mass transfer rates were studied in rabbits
undergoing control dialyses and dialyses with intraperitoneal histamine,
or its receptor antagonists alone or in combination. These drugs had
negligible effects on peritoneal ultrafiltration and small solute clear-
ances. Histamine raised protein exudation from 1.6 to 2.9 mg/kg/mm, an
effect blocked by its antagonists which given alone did not lower protein
loss. These data demonstrate the existence of histamine receptors in the
peritoneal diffusion barrier and show that they do not control transport
under baseline conditions, but can be blocked should abnormal hista-
mine release occur. Increased peritoneal permeability with sterile
peritonitis was unaffected by ranitidine, suggesting alternative media-
tors.
Numerous drugs, especially vasodilators, have been used
experimentally and clinically to accelerate solute transfer dur-
ing peritoneal dialysis [1—4]. Because increments in the transfer
of large solutes exceed those of small solutes, a simple increase
in solute delivery does not account for the observed changes,
which are attributed at least in part to increments in peritoneal
capillary area or permeability or both.
Nonspecific changes due to simple irritation have been dis-
counted for many of these agents by demonstration of: specific
action, for example, on electrolytes; dose dependency; alter-
ations in accord with known vasoactive properties, such as
those of prostaglandins; effectiveness from the vascular side of
the pentoneum; and pharmacological blockade [1].
Histamine induces dilatation of the fine vasculature of most
regions of the body and causes increased capillary and venular
permeability resulting in outward passage of protein and fluid
into the extravascular spaces [5]. A previous study of histamine
added to peritoneal dialysis demonstrated only a minimal in-
crease in small solute clearance [6]. Yet, direct application of
histamine on the surgically-exposed mesenteric peritoneal
microvasculature has caused a considerable exudation of fluo-
rescent labelled albumin [71. The specificity of these changes
was not studied by histamine receptor blockade.
To examine further the effects of histamine on peritoneal
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solute and fluid fluxes and to demonstrate histamine receptors
in the peritoneal microcirculation, peritoneal dialyses were
conducted in rabbits with histamine or a histamine antagonist,
or both, added to the peritoneal dialysis fluid. To assess the role
of histamine in peritoneal reaction to inflammation, sterile
peritonitis was induced by a chemical irritant with and without
addition of a histamine receptor antagonist.
The most striking effect of histamine on the peritoneal
microvasculature was an increased exudation of protein, an
abnormality that was blocked by both H1 and H2 receptor
antagonists. The increased peritoneal permeability induced by a
chemical peritonitis was not affected by a histamine receptor
antagonist.
Methods
Pentoneal dialyses were conducted in lightly restrained,
alert, intact female New Zealand white rabbits as previously
described [8]. In brief, 75 mllkg of standard dialysis solution, to
which a tracer dose of 203Hg-labelled autologous protein was
added, was instilled percutaneously. Dialysate was sampled
every 12 minutes for one hour. Dialysate volume was calculated
by dilution of the indwelling isotope, absorption below 5% of
the total being considered relatively inconsequential for the 60
minute dialysis. Net ultrafiltration volume equaled the incre-
ment in dialysate volume expressed per kilogram. When di-
vided by the minutes of intraperitoneal dwell, this value equaled
the ultrafiltration rate. The ultrafiltration rate divided by the
mean osmotic gradient defined the ultrafiltration coefficient.
Peritoneal clearances were calculated as dialysate concentra-
tion divided by the concentration in plasma sampled immedi-
ately before dialysis, and this fraction multiplied by volume per
kilogram per minute of intraperitoneal dwell. The data from
each 12-minute period were averaged and the mean of control
values before and after experimental dialyses were averaged to
yield a control value for each animal. Absorptive mass trans-
port of dextrose was calculated as dialysate dextrose concen-
tration multiplied by volume per kilogram at the time of
sampling, and this content subtracted from the initial dialysate
dextrose content. When this value was divided by time and by
the initial dextrose concentration, dextrose clearance was ob-
tained. Mass transport of sodium was calculated as initial
dialysate volume per kilogram multiplied by sodium concentra-
tion and the product subtracted from the final concentration
times volume. When divided by 60 the value was expressed as
transport per minute. Protein elimination was calculated as final
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(60 mm) protein concentration times dialysate volume per
kilogram. By linear regression of values at intermediate times,
a zero intercept was calculated and the increment in protein
content of peritoneal fluid was calculated by subtraction of this
value. All fluid and solute flux values were expressed per
kilogram of body weight.
Studies were conducted in 10 rabbits. Graded doses of
histamine from 0.01 to 10 mglkg were added intraperitoneally,
seeking a dose that gave reproducible increments in protein
elimination and solute and water fluxes. Doses of 0.2 mg/kg or
higher increased protein elimination appreciably and small
solute clearance slightly, a ceiling effect was demonstrated (Fig.
1) and these doses were tolerated without incident. Accord-
ingly, subsequent studies in seven rabbits weighing 4.63 0.52
(SD) kg were performed with histamine doses of 2 mg/kg
intrapentoneally. To determine whether the observed effects
depended on histamine receptors, 10 mg/kg of cimetidine, 3 mg/
kg of ranitidine or 0.36 mg/kg of diphenhydramine were given
with 2 mg/kg of histamine intraperitoneally, and solute and fluid
fluxes measured during dialysis. These histamine receptor
antagonists were also administered alone to exclude a direct
effect on pentoneal transfer parameters or an appreciable
baseline, endogenous histamine influence or both. In separate
studies chemical peritonitis was induced by instilling 10 mg/kg
of sodium desoxycholate, a known peritoneal irritant. To de-
termine whether the transport changes accompanying sterile
peritonitis are mediated in part by histamine, sodium desoxy-
cholate (10 mg/kg) was also instilled with 3 mg/kg of ranitidine.
Osmolality was measured by freezing-point depression; so-
dium and potassium were estimated by flame photometry; urea,
glucose and phosphate were determined colorimetrically, and
protein concentrations were measured by a dye-binding assay
[9].
Results of experimental dialyses were compared to control
values by paired r-testing. This statistic was also used to
compare the results of experimental dialyses with and without
histamine antagonists. A P value below 0.05 was considered
significant. Control dialyses performed after experimental dial-
yses did not differ from those performed before test procedures
in any of the parameters evaluated, excluding a carry-over or
sequence effect. Different drugs were evaluated after an interval
of at least six days.
Results
The net ultrafiltration rate with histamine was 0.33 ml/kglmin
compared to 0.28 mI/kg/mm during control dialyses. None of
the drugs alone or in combination raised the ultrafiltration rate
(Fig. 2). With diphenhydramine or with histamine plus either H2
blocker, the net ultrafiltration rate was below control values,
0.19 to 0.23 mI/kg/mm (P <0.04). The ultrafiltration coefficient
was 8.6 pJ/kg/min/mOsm in control dialyses. Although it was
higher with histamine (14.2 .dlkg/minlmOsm, P < 0.05), it was
..L_ also higher with cimetidine and with ranitidine and did not
follow an agonist/antagonist pattern.
Compared to control values of 27 Eq/kgImmn, mass transport
of sodium was higher with histamine, (41 p.Eq/kg/min, P <
0.08), and decreased significantly (P < 0.02) with H2 blockers to
18 and 19 tsEq/kg/min.
The peritoneal urea clearance in control dialyses was 477 ,u,1I
kg/mm (Fig. 3). Neither histamine nor its antagonists alone or in
combination raised urea clearance. H2 receptor antagonists
combined with histamine decreased urea clearances somewhat.
The peritoneal clearance of potassium increased slightly from
1,041 to 1,161 slJkg/min when 2 mg/kg of histamine was added
to the dialysis fluid. When H2 receptor antagonists were added
with histamine to the dialysis fluid, the clearances were lowered
significantly. Diphenhydramine alone also reduced the potas-
sium clearances.
The control phosphorus clearance was 148 p.1/kg/mm. Phos-
phorus clearance was higher with all drugs alone and in com-
bination. The instilled solution tested negatively for phospho-
rus.
The inward clearance of glucose averaged 98 p.11kg/mm in
control dialyses. Neither histamine nor cimetidine affected
glucose transport, but higher values were measured with rani-
tidine and with diphenhydramine.
After 60 minutes the mean control dextrose gradient from
dialysate to plasma decreased to 71% of the initial value. With
histamine this value was slightly lower (68%, P < 0.06) at 60
minutes, an effect that was not completely blocked by the
receptor antagonists and is consistent with an increased glucose
absorption or ultrafiltrate volume, or both.
With control dialyses, protein elimination was 1.6 mg/kg/mm
(Fig. 4). With intraperitoneal histamine (2.0 mg/kg) this value
increased to 2.9 mg/kg/mm (P < 0.02). This histamine dose
increased mean dialysate protein concentration at 60 minutes
from 917 p.gIml to 1,478 p.glml (P < 0.02). Hence, increased
elimination of protein did not depend on a higher dialysate
volume. As Figure 1 shows, a substantial increase in protein
elimination occurred with all histamine doses of 0.2 mg/kg or
higher. To exclude drainage of excessive residual protein, the
intercept or zero time protein content was calculated. This
value was not affected by histamine or its antagonists, alone or
in combination. When the zero time value was subtracted from
the elimination rate, an incremental protein elimination value
was calculated. As shown in Figure 4, this value also increased
with histamine (P < 0.01). None of the histamine receptor
antagonists given alone affected the increment in protein elim-
ination, but diphenhydrammne decreased the gross protein loss
somewhat. With histamine and diphenhydramine combined, the
increment in protein elimination exceeded control values (P <
0.02) but was also less than the value with histamine alone (P <
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Fig. 1. Proteinelimination (•) intoperitoneal dialysate and potassium
clearance (0) expressed as percent of control values are shown in
relation to histamine dose.
0.05). When either H2 receptor blocker was added to histamine,
protein elimination was lower (P < 0.03), as was the increment
in protein elimination (P <0.01), and neither parameter differed
from control values.
The addition of sodium desoxycholate to the peritoneal
dialysis fluid caused a rise in urea and phosphate clearances
(each P < 0.01) and a tendency toward higher potassium and
dextrose clearances (Fig. 5). The increment in protein excretion
increased markedly (P < 0.01). After the addition of ranitidine
all these changes persisted. The modest decrement in ultrafil-
tration rate induced by sodium desoxycholate from 283 to 264
d/kg/min was unaffected by ranitidine.
Discussion
The results show that there are histamine receptors in the
peritoneum. A marked increase in protein elimination into the
peritoneum occurred after the addition of histamine. This
increment did not depend on a change in ultrafiltration volume
because the dialysate protein concentration increased. The
mean change in the net ultrafiltration rate of 50 d/kg/min
represents only 2% of the dialysate volume per minute, whereas
the dialysate protein concentration nearly doubled. Similarly, a
considerable change in the dialysate absorptive rate of about 20
dIkWmin would affect protein elimination only minimally in
one hour. Ascitic fluid protein prior to dialysis was not different
in control dialyses compared to those with drugs added to the
dialysis solution. Hence, the increment in peritoneal dialysate
protein during the period of dialysis was greater when histamine
was added.
Increased protein exudation can be attributed to an increase
in mesenteric capillary permeability, a known effect of hista-
mine [10] not previously demonstrated (agonist/antagonist) in
the peritoneal diffusion barrier. Increased capillary permeabil-
ity can occur below the threshold vasodilatory dose and is
mediated by both H1 and H2 receptors [10], and was blocked by
their respective antagonists. This protein exudation excludes a
nonspecific effect of histamine or contaminants indicating that it
indeed can affect peritoneal permeability. Although a basal
level of histamine is detectable in blood [11], it is mostly stored
in basophils. Hence, the addition of histamine receptor blockers
alone did not reduce protein elimination into dialysate below
control levels. These agents can limit the open permeability of
the peritoneum only when exaggerated by excess histamine, not
in the basal state. Hence, this study indicates that clinical use of
histamine antagonists would not impede peritoneal dialysis.
Because histamine is rapidly metabolized, it has only tran-
sient effects when injected intravenously as a bolus [5]. It is a
small molecule (111 daltons) so it should cross the peritoneum
at a rate comparable to that of creatinine (113 daltons), that is,
close to 0,5 mI/kg/mm. This rate would not remove half of the
instilled histamine within an hour. Hence, the increment in
protein elimination was detected for the entire 60-minute dial-
ysis period. Because of the rapid absorption, however, an effect
of absorbed histamine cannot be distinguished from a local
effect on the mesothelial side of the peritoneal capillary.
Inhibition by the histamine receptor antagonists is competi-
tive. It was complete with H2 antagonists, suggesting that H1
agonists alone are inconsequential in this system. But partial
blockade occurred with the H1 antagonists diphenhydramine,
suggesting a contributory role for H1 receptors.
Histamine is also a potent vasodilator. Because vasodilators
augment peritoneal clearances of small solutes, it might seem
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Fig. 2. Ultrafiltration rate (0) and ultrafiltration coefficient () SD are shown for control peritoneal dialyses and those with drugs added to the
dialysis solution. H2 indicates histamine 2 mg/kg; C10, cimetidine 10 mg/kg; R3, ranitidine 3 mg/kg; D04, diphenhydramine 0.4 mg/kg. None of the
drugs increased the ultrafiltration rate compared to the values of duplicate control dialyses in the same 7 animals. Changes in the ultrafiltration
coefficient did not follow an agonist/antagonist pattern.
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Fig. 3. Peritoneal clearance of small solutes during control dialyses and those with drugs added intraperitoneally. Abbreviations are in Figure 2.
Clearances with drugs differ modestly from control values without a pattern of agonist/antagonist action. Phosphorus clearances are higher with
all drugs alone or in combination.
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that a substantial increase in these clearances would be ex-
pected with this high dose of histamine. An increase in perito-
neat clearances to about 110% of baseline values has been
reported previously [6]. We cannot distinguish with confidence
such minor increments in urea or potassium mass transport.
The minimal effect of histamine on small solute clearances
and on ultrafiltration could be attributed to more widespread
vasodilation because of absorbed histamine. It is recognized
that vasodilators augment peritoneal clearance only when ad-
ministered locally, or when splanchnic vasculature is preferen-
tially affected [11. However, both nitroprusside and isoproter-
enol are small enough to be absorbed substantially from the
peritoneum, yet they increase peritoneal mass transport of
small solutes [2, 121. It must be emphasized that changes in
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Fig. 4. Protein elimination () and the increment above basal ascitic
fluid protein content (0) increase significantly with histamine, an effect
that is blocked by H1 or H2 receptor antagonists. Abbreviations are in
Figure 2.
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Fig. 5. Peritoneal clearances of small solutes and protein loss increase
with intraperitoneal Na desoxycholate, an irritant. These changes are
not blocked by ranitidine. Symbols are: () control; () desoxy-
cholate; (0) deoxycholate ÷ ranitidine.
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ultrafiltration rates were small compared to those in clearances
which were determined mostly by alterations in dialysate solute
accumulation.
Recently we showed that pretreatment of rabbits with dehy-
droergotamine, which reduces plasma volume by increasing
ultrafiltration through somatic capillaries, causes a reduction in
peritoneal clearances and ultrafiltration [13]. Protein loss into
the peritoneum with histamine would represent 5% to 10% of
plasma protein, sufficient to reduce plasma volume. Although
this could contribute to inhibiting peritoneal clearance of small
solutes and ultrafiltration, protein elimination into the perito-
neum was even greater with instillation of the irritant, sodium
desoxycholate. More extensive loss of plasma proteins and
volume by a systemic effect of histamine would exaggerate
plasma volume reduction and might blunt the local vasodilatory
effect on peritoneal clearances of small solutes.
The increase in phosphate clearance with the addition of
drugs to the peritoneal dialysis solution could not be explained
by the calculated phosphorus concentration of any of the agents
added or by the negligible phosphorus concentration of the
instilled solution. A generalized increase in permeability to
small solutes is excluded by the urea and potassium clearance.
Whether histamine or its receptor antagonists affect the anionic
charge on the peritoneal capillary wall [14] has not been
studied.
Because the effects of histamine are blocked by H1 or H2
receptor antagonists, the effect of such agents on other causes
of increased peritoneal loss of protein can be studied. Previ-
ously we showed that sodium desoxycholate causes a sterile
peritonitis with increased protein elimination [15]. In these
studies, increased protein loss into peritoneal dialysate as well
as increased clearances were again demonstrated with the
intraperitoneal instillation of sodium desoxycholate. These in-
crements persisted when ranitidine was combined with sodium
desoxycholate, suggesting that histamine does not mediate the
increased peritoneal permeability accompanying this form of
sterile peritonitis. Although a combination of H1 and H2 recep-
tor antagonists might have decreased protein exudation in this
model, such a combination was not necessary to block directly
added histamine. It has been shown that augmented protein loss
associated with bacterial peritonitis can be reduced by inhibi-
tion of prostaglandin synthetase [16]. Although histamine did
not appear to mediate capillary leakage of protein in sterile
peritonitis, it may be involved in the pathogenesis of hypersen-
sitivity reactions to drugs, leachables or contaminants of the
dialysis solution. Histamine receptor blockers would be thera-
peutic in such circumstances.
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